Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41

• S. Moses Dennison,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Laura L. Sutherland,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Frederick H. Jaeger,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Kara M. Anasti,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Robert Parks,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Shelley Stewart,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Cindy Bowman,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Shi-Mao Xia,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Ruijun Zhang,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Xiaoying Shen,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Richard M. Scearce,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Gilad Ofek,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Yongping Yang,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Peter D. Kwong,

  Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Sampa Santra,

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center, Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Hua-Xin Liao,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Georgia Tomaras,

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Norman L. Letvin,

  Affiliation Department of Medicine, Beth Israel Deaconess Medical Center, Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Bing Chen,

  Affiliation Division of Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• S. Munir Alam ,

  * E-mail: alam0004@mc.duke.edu (SMA); hayne002@mc.duke.edu (BFH)

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
•  [ ... ],
• Barton F. Haynes

  * E-mail: alam0004@mc.duke.edu (SMA); hayne002@mc.duke.edu (BFH)

  Affiliation Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• [ view all ]
• [ view less ]